Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
iQIYI price target lowered to $2.60 from $3.90 at Nomura » 06:09
11/24/22
11/24
06:09
11/24/22
06:09
IQ

iQIYI

$2.49 /

+0.06 (+2.47%)

Nomura analyst Thomas…

Nomura analyst Thomas Shen lowered the firm's price target on iQIYI to $2.60 from $3.90 and keeps a Neutral rating on the shares. The company's sales recovery could remain tepid going into next year due to a weakening outlook for advertising, Shen tells investors in a research note.

ShowHide Related Items >><<
IQ iQIYI
$2.49 /

+0.06 (+2.47%)

IQ iQIYI
$2.49 /

+0.06 (+2.47%)

11/23/22 HSBC
iQIYI price target lowered to $2.60 from $4.00 at HSBC
11/23/22 Morgan Stanley
iQIYI price target raised to $2.70 from $2.50 at Morgan Stanley
10/18/22 OTR Global
iQIYI upgraded to Mixed from Negative view at OTR Global
10/14/22 Citi
Citi cuts iQIYI target to $4, opens 'negative Catalyst Watch'
IQ iQIYI
$2.49 /

+0.06 (+2.47%)

IQ iQIYI
$2.49 /

+0.06 (+2.47%)

IQ iQIYI
$2.49 /

+0.06 (+2.47%)

IQ iQIYI
$2.49 /

+0.06 (+2.47%)

Recommendations
iQIYI price target lowered to $2.60 from $4.00 at HSBC » 08:19
11/23/22
11/23
08:19
11/23/22
08:19
IQ

iQIYI

$2.43 /

-0.435 (-15.21%)

HSBC analyst Charlene Liu…

HSBC analyst Charlene Liu lowered the firm's price target on iQIYI to $2.60 from $4.00 and keeps a Hold rating on the shares. Reduced content investment and marketing spend are the key drivers of profitability and cash flow, but Liu continues to see top line challenges from macro, weak users and ad sentiment, the analyst tells investors in a research note.

ShowHide Related Items >><<
IQ iQIYI
$2.43 /

-0.435 (-15.21%)

IQ iQIYI
$2.43 /

-0.435 (-15.21%)

11/23/22 Morgan Stanley
iQIYI price target raised to $2.70 from $2.50 at Morgan Stanley
10/18/22 OTR Global
iQIYI upgraded to Mixed from Negative view at OTR Global
10/14/22 Citi
Citi cuts iQIYI target to $4, opens 'negative Catalyst Watch'
09/07/22 JPMorgan
iQIYI assumed with an Overweight at JPMorgan
IQ iQIYI
$2.43 /

-0.435 (-15.21%)

IQ iQIYI
$2.43 /

-0.435 (-15.21%)

IQ iQIYI
$2.43 /

-0.435 (-15.21%)

IQ iQIYI
$2.43 /

-0.435 (-15.21%)

Recommendations
iQIYI price target raised to $2.70 from $2.50 at Morgan Stanley » 07:29
11/23/22
11/23
07:29
11/23/22
07:29
IQ

iQIYI

$2.43 /

-0.435 (-15.21%)

Morgan Stanley analyst…

Morgan Stanley analyst Rebecca Xu raised the firm's price target on iQIYI to $2.70 from $2.50 and keeps an Underweight rating on the shares. While Q3 was "a beat across the board" and Xu expects sequential improvement to continue, she maintains her Underweight rating given still-lingering growth concerns and a liquidity overhang.

ShowHide Related Items >><<
IQ iQIYI
$2.43 /

-0.435 (-15.21%)

IQ iQIYI
$2.43 /

-0.435 (-15.21%)

10/18/22 OTR Global
iQIYI upgraded to Mixed from Negative view at OTR Global
10/14/22 Citi
Citi cuts iQIYI target to $4, opens 'negative Catalyst Watch'
09/07/22 JPMorgan
iQIYI assumed with an Overweight at JPMorgan
09/01/22 UBS
UBS upgrades iQIYI to Buy with fundraising overhang alleviated
IQ iQIYI
$2.43 /

-0.435 (-15.21%)

IQ iQIYI
$2.43 /

-0.435 (-15.21%)

IQ iQIYI
$2.43 /

-0.435 (-15.21%)

IQ iQIYI
$2.43 /

-0.435 (-15.21%)

Earnings
iQIYI reports Q3 EPS 3c, consensus (1c) » 05:19
11/22/22
11/22
05:19
11/22/22
05:19
IQ

iQIYI

$2.86 /

+0.08 (+2.88%)

Reports Q3 revenue $1.1B,…

Reports Q3 revenue $1.1B, consensus $1.03B. As of September 30, the company had cash, cash equivalents, restricted cash and short-term investments of $709.5M. "We have completed an iconic turnaround during the first three quarters this year, with business performance far exceeding our targets set at the beginning of the year." commented Yu Gong, founder, director, and CEO of iQIYI. "Our original blockbusters drove significant net subscriber additions within the quarter, further expanding our market leadership. As a result, we achieved operating profit growth while continuing to gain market share. We remain confident in our ability to generate value for our stakeholders who share our belief in the prospects of long-form video."

ShowHide Related Items >><<
IQ iQIYI
$2.86 /

+0.08 (+2.88%)

IQ iQIYI
$2.86 /

+0.08 (+2.88%)

10/18/22 OTR Global
iQIYI upgraded to Mixed from Negative view at OTR Global
10/14/22 Citi
Citi cuts iQIYI target to $4, opens 'negative Catalyst Watch'
09/07/22 JPMorgan
iQIYI assumed with an Overweight at JPMorgan
09/01/22 UBS
UBS upgrades iQIYI to Buy with fundraising overhang alleviated
IQ iQIYI
$2.86 /

+0.08 (+2.88%)

IQ iQIYI
$2.86 /

+0.08 (+2.88%)

IQ iQIYI
$2.86 /

+0.08 (+2.88%)

IQ iQIYI
$2.86 /

+0.08 (+2.88%)

Options
Largest borrow rate increases among liquid names » 08:45
11/04/22
11/04
08:45
11/04/22
08:45
FLNG

Flex LNG

$32.93 /

+0.63 (+1.95%)

, GOL

Gol Linhas

$3.84 /

+0.265 (+7.42%)

, UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$9.68 /

-0.36 (-3.59%)

, PLTK

Playtika

$8.97 /

-0.205 (-2.23%)

, IQ

iQIYI

$2.20 /

+0.06 (+2.81%)

, TBT

ProShares UltraShort 20+ yr Trsry

$35.88 /

+0.4 (+1.13%)

, IBB

iShares Nasdaq Biotechnology Index

$127.97 /

+0.28 (+0.22%)

, TRQ

Turquoise Hill

$30.66 /

-0.1 (-0.33%)

, DKS

Dick's Sporting

$112.52 /

+1.26 (+1.13%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Flex LNG Limited (FLNG) 5.65% +3.43, GOL Linhas (GOL) 22.22% +1.49, ProShares Ultra VIX Short Term Futures (UVXY) 8.85% +0.44, Playtika Holding Corp (PLTK) 1.02% +0.44, iQiyi (IQ) 0.73% +0.31, ProShares UltraShort Lehman 20 plus Year Treasury (TBT) 5.37% +0.22, iShares Nasdaq Biotechnology Index Fund (IBB) 1.88% +0.14, Turquoise Hill (TRQ) 0.55% +0.14, Dicks (DKS) 0.54% +0.14, and ProShares UltraPro Dow 30 (UDOW) 8.44% +0.10.

ShowHide Related Items >><<
TRQ Turquoise Hill
$30.66 /

-0.1 (-0.33%)

PLTK Playtika
$8.97 /

-0.205 (-2.23%)

IQ iQIYI
$2.20 /

+0.06 (+2.81%)

GOL Gol Linhas
$3.84 /

+0.265 (+7.42%)

FLNG Flex LNG
$32.93 /

+0.63 (+1.95%)

DKS Dick's Sporting
$112.52 /

+1.26 (+1.13%)

FLNG Flex LNG
$32.93 /

+0.63 (+1.95%)

11/02/22 Danske Bank
Flex LNG upgraded to Buy from Hold at Danske Bank
08/25/22 Danske Bank
Flex LNG downgraded to Hold from Buy at Danske Bank
08/23/22 Kepler Cheuvreux
Flex LNG downgraded to Hold from Buy at Kepler Cheuvreux
07/20/22 Jefferies
Flex LNG initiated with a Hold at Jefferies
GOL Gol Linhas
$3.84 /

+0.265 (+7.42%)

07/19/22 Deutsche Bank
Gol Linhas price target lowered to $6 from $10 at Deutsche Bank
07/06/22 Barclays
Gol Linhas downgraded to Equal Weight from Overweight at Barclays
04/26/22 Seaport Global
Gol Linhas upgraded to Buy from Neutral at Seaport Global
03/07/22 Seaport Global
Gol Linhas downgraded to Neutral from Buy at Seaport Global
UVXY ProShares Trust Ultra VIX Short Term Futures ETF
$9.68 /

-0.36 (-3.59%)

PLTK Playtika
$8.97 /

-0.205 (-2.23%)

10/12/22 BTIG
Playtika downgraded to Neutral from Buy at BTIG
08/23/22 BofA
Playtika resumed with an Underperform at BofA
08/23/22 BofA
Playtika resumed with an Underperform at BofA
08/05/22 MKM Partners
Playtika downgraded to Neutral from Buy at MKM Partners
IQ iQIYI
$2.20 /

+0.06 (+2.81%)

10/18/22 OTR Global
iQIYI upgraded to Mixed from Negative view at OTR Global
10/14/22 Citi
Citi cuts iQIYI target to $4, opens 'negative Catalyst Watch'
09/07/22 JPMorgan
iQIYI assumed with an Overweight at JPMorgan
09/01/22 UBS
UBS upgrades iQIYI to Buy with fundraising overhang alleviated
TBT ProShares UltraShort 20+ yr Trsry
$35.88 /

+0.4 (+1.13%)

IBB iShares Nasdaq Biotechnology Index
$127.97 /

+0.28 (+0.22%)

TRQ Turquoise Hill
$30.66 /

-0.1 (-0.33%)

10/13/22 Scotiabank
Turquoise Hill downgraded to Sector Perform from Outperform at Scotiabank
10/13/22 Canaccord
Turquoise Hill downgraded to Hold from Buy at Canaccord
09/06/22 Scotiabank
Mining may be on 'precipice of new M&A cycle,' says Scotiabank
08/25/22 TD Securities
Turquoise Hill price target raised to C$40 from C$34 at TD Securities
DKS Dick's Sporting
$112.52 /

+1.26 (+1.13%)

10/20/22 Oppenheimer
Oppenheimer upgrades Dick's Sporting to Outperform with $138 price target
10/20/22 Oppenheimer
Dick's Sporting upgraded to Outperform from Perform at Oppenheimer
08/24/22 Evercore ISI
Dick's Sporting price target raised to $160 from $120 at Evercore ISI
08/24/22 DA Davidson
Dick's Sporting price target raised to $130 from $120 at DA Davidson
TRQ Turquoise Hill
$30.66 /

-0.1 (-0.33%)

PLTK Playtika
$8.97 /

-0.205 (-2.23%)

IQ iQIYI
$2.20 /

+0.06 (+2.81%)

GOL Gol Linhas
$3.84 /

+0.265 (+7.42%)

DKS Dick's Sporting
$112.52 /

+1.26 (+1.13%)

PLTK Playtika
$8.97 /

-0.205 (-2.23%)

IQ iQIYI
$2.20 /

+0.06 (+2.81%)

FLNG Flex LNG
$32.93 /

+0.63 (+1.95%)

TRQ Turquoise Hill
$30.66 /

-0.1 (-0.33%)

PLTK Playtika
$8.97 /

-0.205 (-2.23%)

IQ iQIYI
$2.20 /

+0.06 (+2.81%)

GOL Gol Linhas
$3.84 /

+0.265 (+7.42%)

DKS Dick's Sporting
$112.52 /

+1.26 (+1.13%)

UVXY ProShares Trust Ultra VIX Short Term Futures ETF
$9.68 /

-0.36 (-3.59%)

TRQ Turquoise Hill
$30.66 /

-0.1 (-0.33%)

TBT ProShares UltraShort 20+ yr Trsry
$35.88 /

+0.4 (+1.13%)

PLTK Playtika
$8.97 /

-0.205 (-2.23%)

IQ iQIYI
$2.20 /

+0.06 (+2.81%)

GOL Gol Linhas
$3.84 /

+0.265 (+7.42%)

FLNG Flex LNG
$32.93 /

+0.63 (+1.95%)

DKS Dick's Sporting
$112.52 /

+1.26 (+1.13%)

Over a month ago
Upgrade
iQIYI upgraded to Mixed from Negative view at OTR Global » 09:41
10/18/22
10/18
09:41
10/18/22
09:41
IQ

iQIYI

$2.35 /

+ (+0.00%)

OTR Global upgraded its…

OTR Global upgraded its view on iQIYI's advertising business to Mixed from Negative, citing checks.

ShowHide Related Items >><<
IQ iQIYI
$2.35 /

+ (+0.00%)

IQ iQIYI
$2.35 /

+ (+0.00%)

10/14/22 Citi
Citi cuts iQIYI target to $4, opens 'negative Catalyst Watch'
09/07/22 JPMorgan
iQIYI assumed with an Overweight at JPMorgan
09/01/22 UBS
UBS upgrades iQIYI to Buy with fundraising overhang alleviated
09/01/22 UBS
iQIYI upgraded to Buy from Neutral at UBS
IQ iQIYI
$2.35 /

+ (+0.00%)

IQ iQIYI
$2.35 /

+ (+0.00%)

IQ iQIYI
$2.35 /

+ (+0.00%)

IQ iQIYI
$2.35 /

+ (+0.00%)

Recommendations
Citi cuts iQIYI target to $4, opens 'negative Catalyst Watch' » 09:31
10/14/22
10/14
09:31
10/14/22
09:31
IQ

iQIYI

$2.30 /

+0.025 (+1.10%)

Citi analyst Alicia Yap…

Citi analyst Alicia Yap lowered the firm's price target on iQIYI to $4 from $6.50 and keeps a Buy rating on the shares. The analyst also opened a "30-day negative Catalyst Watch" into the Q3 results given potential risk to forward consensus estimates. Yap reduced Q4 and out years revenue and profit assumptions to reflect rising uncertainty on the macro outlook, which she says could further weigh on iQIYI's online advertising recovery trend and membership stickiness. With that said, Yap believes visibility on iQIYI's "sustainable profitability trend is improving."

ShowHide Related Items >><<
IQ iQIYI
$2.30 /

+0.025 (+1.10%)

IQ iQIYI
$2.30 /

+0.025 (+1.10%)

09/07/22 JPMorgan
iQIYI assumed with an Overweight at JPMorgan
09/01/22 UBS
UBS upgrades iQIYI to Buy with fundraising overhang alleviated
09/01/22 UBS
iQIYI upgraded to Buy from Neutral at UBS
08/31/22 Benchmark
iQIYI price target lowered to $6 from $7 at Benchmark
IQ iQIYI
$2.30 /

+0.025 (+1.10%)

IQ iQIYI
$2.30 /

+0.025 (+1.10%)

IQ iQIYI
$2.30 /

+0.025 (+1.10%)

IQ iQIYI
$2.30 /

+0.025 (+1.10%)

Hot Stocks
iQIYI announces new XPeng SUV series to feature 5D in-vehicle cinema » 05:10
09/29/22
09/29
05:10
09/29/22
05:10
IQ

iQIYI

$2.89 /

-0.025 (-0.86%)

, XPEV

XPeng

$13.32 /

-0.35 (-2.56%)

iQIYI (IQ) announced that…

iQIYI (IQ) announced that launched on September 21, the new XPeng (XPEV) Motor SUV G9 series would feature iQIYI's latest 5D in-vehicle cinema, marking a first in China's in-vehicle entertainment development. Unlike traditional in-vehicle entertainment experience, the new 5D cinema iQIYI developed in partnership with XPeng integrates various physical features of the vehicle cockpit in the delivery of content, hence providing viewers a full-sensory, 5D immersive viewing experience.

ShowHide Related Items >><<
XPEV XPeng
$13.32 /

-0.35 (-2.56%)

IQ iQIYI
$2.89 /

-0.025 (-0.86%)

IQ iQIYI
$2.89 /

-0.025 (-0.86%)

09/07/22 JPMorgan
iQIYI assumed with an Overweight at JPMorgan
09/01/22 UBS
UBS upgrades iQIYI to Buy with fundraising overhang alleviated
09/01/22 UBS
iQIYI upgraded to Buy from Neutral at UBS
08/31/22 Benchmark
iQIYI price target lowered to $6 from $7 at Benchmark
XPEV XPeng
$13.32 /

-0.35 (-2.56%)

09/22/22 Morgan Stanley
XPeng pullback triggered by lack of meaningful G9 surprise, says Morgan Stanley
09/13/22 Deutsche Bank
XPeng named short-term buy idea at Deutsche Bank
09/06/22 Morgan Stanley
September 'crunch time' for China EV makers, says Morgan Stanley
08/24/22 Citi
XPeng price target lowered to $27.87 from $51.59 at Citi
XPEV XPeng
$13.32 /

-0.35 (-2.56%)

IQ iQIYI
$2.89 /

-0.025 (-0.86%)

XPEV XPeng
$13.32 /

-0.35 (-2.56%)

IQ iQIYI
$2.89 /

-0.025 (-0.86%)

XPEV XPeng
$13.32 /

-0.35 (-2.56%)

IQ iQIYI
$2.89 /

-0.025 (-0.86%)

XPEV XPeng
$13.32 /

-0.35 (-2.56%)

IQ iQIYI
$2.89 /

-0.025 (-0.86%)

Hot Stocks
iQIYI announces 'Shining for One Thing' series surpasses RMB 100M in revenue » 05:12
09/19/22
09/19
05:12
09/19/22
05:12
IQ

iQIYI

$3.13 /

-0.205 (-6.15%)

iQIYI announced recently…

iQIYI announced recently that "Shining for One Thing," a series that streams exclusively on iQIYI via the revenue sharing model, topped RMB 100M in the revenue it generates. iQIYI will continue to work with producers and help driving the creation of premium content by supporting producers financially and offering content promotional and other platform services.

ShowHide Related Items >><<
IQ iQIYI
$3.13 /

-0.205 (-6.15%)

IQ iQIYI
$3.13 /

-0.205 (-6.15%)

09/07/22 JPMorgan
iQIYI assumed with an Overweight at JPMorgan
09/01/22 UBS
UBS upgrades iQIYI to Buy with fundraising overhang alleviated
09/01/22 UBS
iQIYI upgraded to Buy from Neutral at UBS
08/31/22 Benchmark
iQIYI price target lowered to $6 from $7 at Benchmark
IQ iQIYI
$3.13 /

-0.205 (-6.15%)

IQ iQIYI
$3.13 /

-0.205 (-6.15%)

IQ iQIYI
$3.13 /

-0.205 (-6.15%)

IQ iQIYI
$3.13 /

-0.205 (-6.15%)

Initiation
iQIYI assumed with an Overweight at JPMorgan » 09:10
09/07/22
09/07
09:10
09/07/22
09:10
IQ

iQIYI

$3.04 /

-0.49 (-13.90%)

JPMorgan analyst Daniel…

JPMorgan analyst Daniel Chen assumed coverage of iQIYI with an Overweight rating and $7 price target, which he notes implies 130% potential upside. The share price had underperformed the China internet index in 2020/21 as investors took a cautious view on its cash burn and competition, but has outperformed year-to-date on investors' positive sentiment after it achieved its first breakeven quarter in Q1, Chen notes. He believes a more benign competitive landscape in the China long-form video market is going to support a steady video subscription ARPU increase and margin expansion and he expects share price momentum to continue, Chen said.

ShowHide Related Items >><<
IQ iQIYI
$3.04 /

-0.49 (-13.90%)

IQ iQIYI
$3.04 /

-0.49 (-13.90%)

09/01/22 UBS
UBS upgrades iQIYI to Buy with fundraising overhang alleviated
09/01/22 UBS
iQIYI upgraded to Buy from Neutral at UBS
08/31/22 Benchmark
iQIYI price target lowered to $6 from $7 at Benchmark
08/23/22 Macquarie
iQIYI initiated with Underperform on 'growth obstacles' at Macquarie
IQ iQIYI
$3.04 /

-0.49 (-13.90%)

IQ iQIYI
$3.04 /

-0.49 (-13.90%)

IQ iQIYI
$3.04 /

-0.49 (-13.90%)

IQ iQIYI
$3.04 /

-0.49 (-13.90%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.